ArticleDiabetes, obesity & metabolism2025
State-level prevalence of chronic conditions co-occurring with obesity among US adults.
Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Usefulness of a virtual reality programme for body self-image in obese and overweight patients: a focus on gender differences - a randomised trial.Archives of public health = Archives belges de sante publique · 2026Article
- State-level prevalence of chronic conditions co-occurring with obesity among US adults.Diabetes, obesity & metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsRecent estimates of chronic conditions (CCs) among adults with obesity are lacking. This study analysed state-representative data to assess the prevalence of CCs that co-occur with obesity. MATERIALS AND
methodsWe used 2021-2022 Behavioural Risk Factor Surveillance System data to assess the age-standardised prevalence of nine CCs among adults with obesity (body mass index ≥30 kg/m
resultsThe most prevalent CCs with obesity were hypertension (42.2%), high cholesterol (37.4%), arthritis (30.2%), and depression (26.4%), followed by diabetes (16.7%), asthma (13.4%), heart disease/stroke (9.2%), cancer (6.9%), and kidney disease (3.9%). Prevalence generally increased with age except for depression and asthma, which were lower among those 65 and older compared to those aged 18-44 (p < 0.001). There was an inverse relationship between CCs prevalence and household income. Significant differences were observed across sex, race/ethnicity, education, employment status, healthcare access, and obesity class. Across states and territories, hypertension was the most prevalent CC, ranging from 31.8% in the Virgin Islands (VI) to 51.6% in Alabama, followed by high cholesterol (28.1% in VI to 44.9% in Guam). Other CCs also showed significant variation by state and territory.
conclusionsAmong US adults with obesity, the age-standardised prevalence of CCs varies significantly across population subgroups and states. Awareness of these differences can help clinicians, public health officials, and decision-makers address chronic disease prevention and obesity management for populations at higher risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.